Imatinib tablets (VEENAT 400)
Imatinib Tablets VEENAT 400 mg is a targeted therapy medication widely used in the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It works by blocking abnormal protein activity that promotes cancer cell growth, helping to slow disease progression effectively. This medicine is known for its precision in targeting cancer cells while minimizing damage to healthy cells. Manufactured under strict quality standards, it ensures safety, consistency, and effectiveness. Imatinib Tablets VEENAT 400 mg is prescribed by healthcare professionals and is an essential part of modern cancer treatment protocols for improved patient outcomes.
Description
Imatinib Tablets VEENAT 400 mg delivers a highly effective targeted therapy designed to treat certain types of cancer, especially chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). This medication works by actively blocking the action of abnormal proteins that signal cancer cells to grow and multiply. By directly targeting these proteins, it slows disease progression and helps the body regain better control over abnormal cell growth.
Doctors widely prescribe Imatinib Tablets VEENAT 400 mg because it offers precise action with fewer effects on healthy cells compared to traditional chemotherapy. Patients benefit from its ability to improve treatment outcomes while maintaining a manageable safety profile. The tablet form allows easy oral administration, making it convenient for long-term therapy under medical supervision.
This medicine plays a crucial role in modern oncology by targeting the root cause of cancer at the molecular level. It helps reduce tumor size, controls disease spread, and supports overall patient stability when used consistently as prescribed. Healthcare professionals carefully determine the dosage based on the patient’s condition, ensuring optimal effectiveness and safety.
Manufacturers produce this medication under strict quality standards to ensure purity, potency, and reliability. Proper storage in a cool and dry place maintains its effectiveness over time. Patients should always follow their doctor’s instructions and attend regular check-ups to monitor progress and response to treatment.
Imatinib Tablets VEENAT 400 mg stands as a trusted solution in targeted cancer therapy, offering hope and improved quality of life to patients undergoing long-term treatment. Its scientifically proven mechanism and consistent performance make it a preferred choice among healthcare providers worldwide.
- Product Name: Imatinib Tablets VEENAT 400 mg
- Generic Name: Imatinib Mesylate
- Strength: 400 mg
- Dosage Form: Oral Tablets
- Therapeutic Class: Anti-Cancer / Tyrosine Kinase Inhibitor
- Indication: Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors (GIST)
- Administration: As directed by a physician
- Packaging: Standard strip/bottle packaging
- Storage: Store in a cool, dry place away from sunlight
